Market News

Petersen Flynn & Dinsmore Lifted Its Aptargroup (ATR) Stake; 5 Analysts Bullish Victrex plc (LON:VCT)

AptarGroup, Inc. (NYSE:ATR) Logo

Petersen Flynn & Dinsmore Inc increased Aptargroup Inc (ATR) stake by 3.04% reported in 2018Q1 SEC filing. Petersen Flynn & Dinsmore Inc acquired 6,211 shares as Aptargroup Inc (ATR)’s stock rose 3.64%. The Petersen Flynn & Dinsmore Inc holds 210,439 shares with $18.90M value, up from 204,228 last quarter. Aptargroup Inc now has $5.90B valuation. The stock decreased 0.29% or $0.28 during the last trading session, reaching $94.58. About 168,103 shares traded. AptarGroup, Inc. (NYSE:ATR) has risen 11.80% since June 15, 2017 and is uptrending. It has underperformed by 0.77% the S&P500. Some Historical ATR News: ; 12/04/2018 – AptarGroup at Wells Fargo Industrials Conference May 8; 26/04/2018 – APTARGROUP INC QTRLY NET SALES $ 703.35 MLN VS $ 601.32 MLN; 26/04/2018 – AptarGroup Sees 2Q Adj EPS 99c-Adj EPS $1.04; 26/04/2018 – APTARGROUP SEES 2Q ADJ EPS 99C TO $1.04, EST. $1.02; 30/05/2018 – Aptar Pharma and Propeller Health Partner to Develop Digital Medicine Platform Across Therapeutic Areas; 26/04/2018 – APTARGROUP SEES 2Q ADJ EPS 99C TO $1.04; 26/04/2018 – APTARGROUP 1Q ADJ EPS 99C; 20/04/2018 – DJ Aptargroup Inc, Inst Holders, 1Q 2018 (ATR); 02/05/2018 – Aptar Adds Capabilities to Better Serve the Growing Color Cosmetics Market; Acquires Reboul, an Established and Innovative; 12/04/2018 – Aptar Food + Beverage and Cheer Pack North America Partner to Launch a Premade No-Spill Spouted Pouch Solution

Among 17 analysts covering Victrex PLC (LON:VCT), 5 have Buy rating, 1 Sell and 11 Hold. Therefore 29% are positive. Victrex PLC had 170 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Monday, February 1 by Liberum Capital. The stock of Victrex plc (LON:VCT) earned “Hold” rating by Numis Securities on Friday, December 16. The firm has “Neutral” rating by JP Morgan given on Wednesday, March 29. Liberum Capital maintained the stock with “Buy” rating in Monday, September 4 report. The firm has “Neutral” rating by JP Morgan given on Thursday, February 11. The firm has “Buy” rating by Liberum Capital given on Monday, May 15. The firm has “Equal Weight” rating by Barclays Capital given on Tuesday, May 2. The firm has “Neutral” rating by BNP Paribas given on Thursday, September 1. The firm has “Add” rating by Peel Hunt given on Monday, February 6. As per Tuesday, October 11, the company rating was maintained by Peel Hunt. See Victrex plc (LON:VCT) latest ratings:

23/05/2018 Broker: HSBC Rating: Hold New Target: GBX 2650.00 Initiates Starts
17/05/2018 Broker: Peel Hunt Rating: Add Old Target: GBX 2400.00 New Target: GBX 2850.00 Maintain
15/05/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 2800.00 New Target: GBX 2850.00 Reiteration
15/05/2018 Broker: JP Morgan Rating: Neutral Old Target: GBX 2580.00 Maintain
14/05/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 2400.00 Maintain
14/05/2018 Broker: Liberum Capital Rating: Buy Old Target: GBX 2825.00 Maintain
08/05/2018 Broker: Peel Hunt Rating: Hold New Target: GBX 2400.00 Maintain
09/04/2018 Broker: Peel Hunt Rating: Hold Old Target: GBX 2400.00 Maintain
05/04/2018 Broker: BNP Paribas Rating: Underperform Old Target: GBX 2200.00 Maintain
03/04/2018 Broker: Liberum Capital Rating: Buy Old Target: GBX 2825.00 Maintain

Victrex plc, through its subsidiaries, makes and sells polymers worldwide. The company has market cap of 2.63 billion GBP. It operates through two divisions, Victrex Polymer Solutions and Invibio Biomaterial Solutions. It has a 26.33 P/E ratio. The firm offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications.

The stock decreased 1.23% or GBX 38 during the last trading session, reaching GBX 3060. About 576,689 shares traded or 122.31% up from the average. Victrex plc (LON:VCT) has 0.00% since June 15, 2017 and is . It has underperformed by 12.57% the S&P500.

Investors sentiment increased to 1.15 in Q1 2018. Its up 0.08, from 1.07 in 2017Q4. It improved, as 12 investors sold ATR shares while 109 reduced holdings. 45 funds opened positions while 94 raised stakes. 55.09 million shares or 0.77% less from 55.52 million shares in 2017Q4 were reported. Sei invested 0% of its portfolio in AptarGroup, Inc. (NYSE:ATR). Garrison Financial accumulated 2.18% or 43,451 shares. Alabama-based Mesirow Fincl Invest has invested 0.17% in AptarGroup, Inc. (NYSE:ATR). Magnetar Finance Ltd Llc has 11,443 shares for 0.03% of their portfolio. Metropolitan Life Insurance Company holds 0% of its portfolio in AptarGroup, Inc. (NYSE:ATR) for 18,557 shares. Pub Employees Retirement Association Of Colorado has 0.01% invested in AptarGroup, Inc. (NYSE:ATR) for 11,253 shares. Stratos Wealth Prns Ltd accumulated 54 shares or 0% of the stock. Jpmorgan Chase holds 2.60 million shares. Benjamin F Edwards And Com reported 3,469 shares or 0.03% of all its holdings. Northern Trust stated it has 0.01% in AptarGroup, Inc. (NYSE:ATR). Thrivent Fincl For Lutherans accumulated 0% or 14,085 shares. Mckinley Carter Wealth invested in 0.25% or 8,597 shares. Citadel Advisors Ltd Liability Co accumulated 4,799 shares or 0% of the stock. Fdx Advsrs invested in 18,014 shares or 0.05% of the stock. Tower Capital Lc (Trc) has 4,413 shares for 0.03% of their portfolio.

AptarGroup, Inc. (NYSE:ATR) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *